InSphero provides superior biological relevance to in vitro testing with its easy-to-use solutions for production, culture and assessment of more organotypic 3D cell culture models. The company's patented 3D cell culture platforms and methods enable large-scale, reproducible production of a broad range of assay-ready 3D InSightTM Microtissues including models derived from liver, pancreas, tumor, heart, brain, and skin. Microtissues are delivered directly to customers, or are accessible through 3D InSightTM Standard Services, where InSphero scientists conduct tailored screening projects with rapid turnaround and strict confidentiality. Supported by a portfolio of 3D-optimized culture media, assay protocols, and imaging solutions, InSphero microtissues and services help to identify promising drugs and toxic liabilities with greater predictivity at early development stages. This enables better pre-clinical decision making, saves development cost and shortens time-to-market.
|Channel:||Website - E-mail - Audio / Video - Social media - Professional online network|
|Audience:||Scientists - Industry - Researchers|
|Purpose:||Regulatory testing - Fundamental studies - Toxicological and safety evaluation - Method development|
|Technology/Tools:||Alternative test methods (in vitro) - Tissue engineering|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.